Arbutus Biopharma Stocks List
|ABUS||F||Arbutus Biopharma Corporation||0.35|
|TLC||C||Taiwan Liposome Company, Ltd.||0.00|
|SCPS||F||Scopus BioPharma Inc.||0.00|
|GERM||D||ETFMG Treatments Testing and Advancements ETF||0.25|
|IBBJ||F||Defiance Nasdaq Junior Biotechnology ETF||0.08|
|IWC||D||iShares Microcap ETF||0.05|
|IBB||D||iShares Nasdaq Biotechnology Index Fund||0.03|
|BIB||D||ProShares Ultra Nasdaq Biotechnology||0.02|
View all Arbutus Biopharma related ETFs...
|Apr 16||ABUS||Introducing Arbutus Biopharma (NASDAQ:ABUS), The Stock That Zoomed 167% In The Last Year|
Arbutus Biopharma Corporation is a publicly traded (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.